Future of GLP-1 Agonists ******** from Ian Blumer, MD, FRCPC, Charles H Best Diabetes Centre, University of Toronto, Toronto, Ontario, Canada, Author of Diabetes for Canadians for Dummies , and Celiac Disease for Dummies Compiled by Farhan Guard and Eric Nielsen, Ambulatory Care Pharmacy rotation students
The others have compelling anecdotal data and decent mechanistic logic, but far fewer robust human trials for fat loss specifically
It provides a structured way to address the reality that not all members will have uniform GLP-1 coverage, without abandoning quality or safety, and while supporting responsible use and measurable outcomes
The amino acid sequence of GLP-1 has remained largely unchanged across mammalian species for millions of years, suggesting its importance to survival and energy regulation